BackAspire Biopharma Holdings Overview

Aspire Biopharma Holdings Total Liabilities

Aspire Biopharma Holdings's total liabilities is $1.8M.

Get informed when a big investor buys or sells

+ Follow
Total Liabilities
$1.78M
83.19% YoYΔ $-8.82M vs prior year quarter

Peer trimmed avg / median

Loading

Aspire Biopharma Holdings Total Liabilities History

Loading

Aspire Biopharma Holdings vs. peers: Total Liabilities Comparison

Loading

Aspire Biopharma Holdings Total Liabilities Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Aspire Biopharma Holdings (ASBP) FAQ

As of the most recent data (June 2026), ASBP shows a total liabilities of $1.8M. That compares with $11M in the prior-year period — down 83.2% year over year. Scroll down for historical charts and peer comparison views.

Compared with the year-ago period, ASBP's total liabilities is now $1.8M (was $11M) — a 83.2% year-over-year decrease. Pairing that YoY change with peer averages gives a clearer picture of whether Aspire Biopharma Holdings is outperforming or lagging.

Tracking ASBP's total liabilities over time shows whether Aspire Biopharma Holdings is scaling, shrinking, or reshaping that part of the business. The current reading is $1.8M That compares with $11M in the prior-year period — down 83.2% year over year. Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.

Besides this total liabilities page, Stockcircle has Aspire Biopharma Holdings's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect total liabilities (currently $1.8M) with ownership activity and broader fundamentals.